Trials | A | B | C | D | E | F | Total score (n/12) |
---|
Blonde 2016 [9] | 2 | 2 | 1 | 2 | 2 | 1 | 10 |
Forst 2014 [10] | 2 | 2 | 1 | 1 | 2 | 1 | 9 |
Neal 2015 [11] | 2 | 1 | 2 | 2 | 2 | 1 | 10 |
Gonzalez 2013 [12] | 2 | 2 | 1 | 2 | 2 | 1 | 10 |
Inagaki 2013 [13] | 2 | 2 | 1 | 1 | 2 | 1 | 9 |
Inagaki 2014 | 2 | 1 | 1 | 1 | 2 | 1 | 8 |
Stenlof 2013 [15] | 2 | 1 | 2 | 2 | 2 | 1 | 10 |
Wilding 2013 [16] | 2 | 1 | 2 | 2 | 2 | 1 | 10 |
Yale 2013 [17] | 2 | 1 | 2 | 2 | 2 | 1 | 10 |
Rosenstock 2012 [18] | 2 | 1 | 2 | 2 | 2 | 1 | 10 |
- A: sequence generation; B: concealment of allocation; C: Blinding of patients; D: Blinding of caregivers; E: Blinding of outcome assessors; F: Follow-up and intention-to treat analysis